TotalMarketCap

Maze Therapeutics

MAZENasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.804 B

$32.47 -2.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Maze Therapeutics (MAZE) has a market capitalization of $1.80B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$167.5M

#2332 by revenue

Earnings

-$131.1M

Loss-making

Shares outstanding

55,549,168

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #36Vir BiotechnologyVIR$1.89B
  2. #37MesoblastMESO$1.83B
  3. #38Maze TherapeuticsMAZE$1.80B
  4. #39AlvotechALVO$1.78B
  5. #40NovavaxNVAX$1.61B

What if Maze Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$508,322.17

Per share 15,655× higher

Bitcoin $1.53T

$27,504.43

Per share 847× higher

Apple $5.02T

$90,294.47

Per share 2,781× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Maze Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.